The Year in Cardiovascular Medicine 2020: Digital Health and Innovation
Advances in digital health and particularly in artificial intelligence (AI) have led us very close to the true implementation of personalized medicine. The year 2020 has brought an exponential increase of studies using various forms of AI, from supervised machine learning to unsupervised deep learning, with applications across all domains of cardiovascular medicine.
AI is now moving from research to implementation, affecting all aspects of clinical cardiology. The studies bringing AI close to clinical practice span from fast clinical and biochemical data analysis and interpretation of results to image analysis, electrocardiogram (ECG) interpretation, arrhythmia detection, or even the use of face recognition to diagnose cardiovascular diseases. We review some of the most exciting development in the field of AI in cardiology, published from fall of 2019 up until now.
Read the full article on Oxford Academic
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy
In these contemporary data from 31 245 patients who are receiving statin therapy, residual inflammatory risk appears to be more…
Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk
JACC Review Topic of the Week. In this review the authors aim to summarize the role of PCAT in cardiac…